Meet Bulbitech at FLORetina-ICOOR 2024
Bulbitech is attending the FLORetina-ICOOR Meeting 2024 (Floretina ICOOR 2024) from December 5th to 8th at the Firenze Fiera convention center in […]
Bulbitech is attending the FLORetina-ICOOR Meeting 2024 (Floretina ICOOR 2024) from December 5th to 8th at the Firenze Fiera convention center in […]
Exciting news for anyone passionate about advancing ophthalmology! Join Bulbitech at the NHS Research Scotland Ophthalmology and Scottish Eye Research and Innovation […]
Innovative Research on Thyroid Eye Disease In a notable achievement at the Innovate Thyroid Eye Disease (TED) 2024 Multidisciplinary Symposium, Dr. Jimmy […]
Bulbitech and Meddoc Medical Research Institute, Norway, in collaboration with the Neurological Department at Oslo University Hospital, will soon release promising results […]
Bulbitech revolutionises eye and neurological disease diagnostics and care. Bulbitech delivers AI-powered eye-tracking technology that screens for ophthalmological and neurological disorders. “Our […]
We’re proud to announce we’ve been shortlisted as one of the 15 companies of the Digital Health’s Rewired 2024 Pitchfest Heaths. Looking […]
We are excited to share with you groundbreaking studies that offer a comprehensive evaluation of BulbiCAM, our leading diagnostic tool. In a […]
Article / News Bulbitech have entered into a strategic distribution agreement with Rodenstock Norge AS Trondheim, 25th of January 2022 Bulbitech is […]
Article / News University Vita Salute becomes clinical research partner of Bulbitech AS Bulbitech is pleased to announce that we have entered […]
Bulbitech is excited to announce that Prof. Dr. rer. nat. Michael Bach has decided to join our clinical advisory board. Professor Bach […]